Results 361 to 370 of about 283,224 (387)

5-Fluorouracil: mechanisms of action and clinical strategies

Nature Reviews. Cancer, 2003
D. Longley, D. Harkin, P. Johnston
semanticscholar   +1 more source

Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer.

Journal of Clinical Oncology, 2000
A. Gramont, A. Figer, M. Seymour, M. Homerin, A. Hmissi, J. Cassidy, C. Boni, H. Cortés-Funes, A. Cervantes, G. Freyer, D. Papamichael, N. Bail, C. Louvet, D. Hendler, F. Braud, C. Wilson, F. Morvan, A. Bonetti   +17 more
semanticscholar   +1 more source

Commentary: Use of Topical Fluorouracil

Archives of Dermatology, 1983
I deeply appreciate the opportunity to reflect on our early experiences with topical fluorouracil at the University of Arkansas, Little Rock. It is difficult for me to realize that 20 years have passed, and I was filled with sadness when I reread the article, knowing that the bright young minds of Calvin Dillaha, MD, and W.
openaire   +3 more sources

Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial

The Lancet, 2000
J. Douillard, D. Cunningham, A. Roth, M. Navarro, R. James, P. Karásek, P. Jandík, T. Iveson, J. Carmichael, M. Alakl, G. Gruia, L. Awad, P. Rougier   +12 more
semanticscholar   +1 more source

5-fluorouracil and other fluoropyrimidines in colorectal cancer: Past, present and future.

Pharmacology and Therapeutics, 2019
Sona Vodenkova, T. Buchler, K. Cervena, V. Veskrnova, P. Vodicka, Veronika Vymetálková   +5 more
semanticscholar   +1 more source

Quercetin synergistically potentiates the anti-metastatic effect of 5-fluorouracil on the MDA-MB-231 breast cancer cell line.

Iranian Journal of Basic Medical Sciences, 2021
Mohammadreza Roshanazadeh, Hossein Babaahmadi Rezaei, Mojtaba Rashidi   +2 more
semanticscholar   +1 more source

Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial.

Journal of Clinical Oncology, 2009
T. André, C. Boni, M. Navarro, J. Tabernero, T. Hickish, C. Topham, A. Bonetti, P. Clingan, J. Bridgewater, F. Rivera, A. de Gramont   +10 more
semanticscholar   +1 more source

Histopathological regression after neoadjuvant docetaxel, oxaliplatin, fluorouracil, and leucovorin versus epirubicin, cisplatin, and fluorouracil or capecitabine in patients with resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4-AIO): results from the phase 2 part of a multice

The Lancet Oncology, 2016
S. Al-Batran, R. Hofheinz, C. Pauligk, H. Kopp, G. Haag, K. Luley, J. Meiler, N. Homann, S. Lorenzen, H. Schmalenberg, S. Probst, M. Koenigsmann, M. Egger, N. Prasnikar, K. Caca, J. Trojan, U. Martens, A. Block, W. Fischbach, R. Mahlberg, M. Clemens, G. Illerhaus, K. Zirlik, D. Behringer, W. Schmiegel, M. Pohl, M. Heike, U. Ronellenfitsch, M. Schuler, W. Bechstein, A. Königsrainer, T. Gaiser, P. Schirmacher, W. Hozaeel, Alexander Reichart, T. Goetze, M. Sievert, E. Jäger, S. Mönig, A. Tannapfel   +39 more
semanticscholar   +1 more source

5-Fluorouracil (z.B. 5-Fluorouracil „Ebewe“)

2002
Patrizia Fürst-Weger, Sabine M. Wassertheurer, Robert M. Mader, Ines Mader, Elisabeth I. Semenitz, Robert Terkola   +5 more
openaire   +2 more sources

Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: results of FFCD 9203.

Journal of Clinical Oncology, 2006
J. Gérard, T. Conroy, F. Bonnetain, O. Bouché, O. Chapet, M. Closon-Dejardin, M. Untereiner, B. Leduc, E. François, J. Maurel, J. Seitz, B. Buecher, R. Mackiewicz, M. Ducreux, L. Bedenne   +14 more
semanticscholar   +1 more source